Serum Adiponectin in Chinese Population and Its Correlation to Cardiovascular and Cerebrovascular Diseases
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-85
SponsorXijing Hospital
About this trial
Adiponectin (Ad) is an abundant protein in human body, and reports have shown that it act as a novel risk factor for brain and heart ischemia injury. This 5 years follow-up study will focus on serum adiponectin concentration, activity and isoforms in Chinese population and its correlation to these diseases.
Eligibility criteria
Qualifiers
available for 5 years of follow-up study
Disqualifiers
Death caused other than cardiovascular and cerebralvascular diseases till the study ends
Floating Population
Pregnancy, lactation, or child bearing women
Tumor
Trial design
Treatments tested in this trial
- Not listed
Trial groups
30,000 Participants
are grouped into 1 trial groupSponsors and collaborators
Source ClinicalTrials.gov